Press release
Biomarkers Market Worth US$ 50 Billion by 2021
New York, December 27: Market Research Engine has published a new report titled as “Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2023”The Biomarkers market is expected to exceed more than US$ 50.0 billion by 2021 growing at around 13% CAGR.
Browse Full Report: http://www.marketresearchengine.com/reportdetails/biomarkers-market
Biomarkers are biological measures used to measure biological states such as blood pressure, cholesterol level and monitor and forecast health level of individual. Biomarkers are used in single or in combination to identify health or disease of individual. Different varieties of biomarkers are used currently for various applications. Every biological system consists of its own biomarkers. Some biomarkers are easy to use, measure and form part of routine medical examinations. Biomarkers are used to estimate health and disease of individual such as diabetes and cardiovascular. Biomarkers are used for detection, screening, diagnosis, treatment and monitoring of cancer.
The Biomarkers market is expected to exceed more than US$ 50.0 billion by 2021 growing at around 13% CAGR. The main driving factors for biomarkers market are increase in number of low cost for conducting clinical trials in developing countries. Rising healthcare expenditure and R&D funding are the major macro drivers of the market. The use of biomarkers in diagnostic process is increasing rapidly due to its more accurate results. The biomarkers also have some restraints such as it contain technical issues related to sample and storage. The testing cost of biomarkers is high. It contains high investment but relatively low cost and benefit ratio.
Download Free Sample Report: http://www.marketresearchengine.com/requestsample/biomarkers-market
This report provides:
1) An overview of the global market for biomarkers and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for biomarkers.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various types of biomarkers with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include QIAGEN N.V. (Netherlands), PerkinElmer, Inc., Merck & Co, Inc., Bio-Rad Laboratories , Enzo Biochem , EKF Diagnostics Holdings plc , Meso Scale Diagnostics, LLC , Singulex, Inc. , BioSims Technologies , Cisbio Bioassays , and Signosis, Inc.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Biomarkers Market has been segmented as below:
By Product Segment Analysis
• Consumable
• Services
• Software
By Type Analysis
• Safety biomarker,
• Efficacy biomarker
• Validation biomarker
By Application Analysis
• Diagnostics development
• Drug discovery & development
• Personalized medicine
• Disease risk assessment
By Disease Indication Analysis
• Cancer
• Cardiovascular disorders
• Neurological disorders
• Immunological disorders
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: http://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomarkers Market Worth US$ 50 Billion by 2021 here
News-ID: 402017 • Views: …
More Releases from (MRE) Reports

Contrast Media Injectors Market share will Increase more than US$ 1.50 Billion B …
In the past few years the demand for Contrast Media Injectors has increased. In contrast media injectors a radio opaque substance is injected in the body of human being for highlighting parts of the body for better diagnoses. Contrast Media Injectors enable radiologist to minutely analyze the normal and abnormal condition of human body.
Research report clearly reflects that by 2025, there will be steady growth of more than US$…
Healthcare Simulation Market is Expected to Cross US$ 2.50 Billion by 2022
The medical simulation market is segmented on the lines of its product and service, end user and geographic region. Based on product and service segmentation it covers simulation training services, simulation software, web based simulation, medical simulation anatomical models and endovascular simulators. Simulation software is further segmented into educational societies, custom consulting services and vender based training. Under simulation software it covers virtual tutors and performance recording software. Based on…
Healthcare API Market is Expected to Exceed US$ 234 Million by 2024
The healthcare API market is segmented on the lines of its services, deployment model, and end user and on regional basis. Based on services segmentation it covers medical device (wearable), payment, remote patient monitoring, appointments and electronic health record access. Under deployment model segmentation it covers cloud based and on premise. End user segmentation covers vendors, patients, healthcare providers and healthcare payers.
Browse Full Report @: https://www.marketresearchengine.com/reportdetails/healthcare-api-market-report
How Big is the…

Hazmat Suits Market is Expected to Exceed US$ 8.0 Billion by 2022
The hazmat suits market is segmented on the lines of its application, end user, safety standards and regional. Based on application segmentation it covers hazardous materials, infection control and biohazard, chemical waste and others. Under end user segmentation the hazmat suits market covers healthcare, utilities, transportation, manufacturing, construction, mining and metallurgy, oil and gas and others. The hazmat suits market is segmented on the lines of its safety standards like…
More Releases for Biomarkers
Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032.
Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and…
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040
This latest report researches the industry structure, sales, revenue,…
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024
This latest report researches the industry structure, sales, revenue,…
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.
The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report…
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help…
Biomarkers Summit
SMi present their 4th annual conference on
Biomarkers Summit
Monday 31st January & Tuesday 1st February 2011
Crowne Plaza The-City, London, UK
Don’t Miss Out - Visit to register your place today
http://www.smi-online.co.uk/preclinical-biomarkers.asp
Sponsored by
Caprotec
Cell Signalling Technology
GVK Bio
Selventa
Millipore Quest Diagnostics
RBM
SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out…